Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02456389 · ClinicalTrials.gov registry record · NA
Perioperative Risk Study
A NA study of Surgery and Tumors, sponsored by Fox Chase Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 1,456
- Enrollment target
- 1
- Study location
NCT02456389: Active NA study of Surgery and Tumors, sponsored by Fox Chase Cancer Center.
NCT02456389 is a NA study of Surgery and Tumors that is active but no longer recruiting, run by Fox Chase Cancer Center. The registered enrollment target is 1,456 participants, below the 52,840-participant average among 120 other Surgery trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02456389, a NA study of Surgery and Tumors, is active but no longer recruiting, sponsored by Fox Chase Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,456 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this trial is to determine if perioperative risk stratification and risk-based, protocol-driven management leads to a reduction in the rate of death or serious complications compared to standard perioperative management in patients undergoing elective major cancer surgery.
Conditions Studied
Interventions
- OTHER Preoperative risk stratification
- OTHER Postoperative risk stratification
- OTHER Risk-based, escalating levels of care
- OTHER Risk-based, escalating levels of monitoring
- OTHER Risk-based, escalating levels of co-management
Study Locations (1)
Pennsylvania
- Fox Chase Cancer Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,456 participants |
| Start Date | 2014-08 |
| Est. Completion | 2025-06 |
| Phase | NA |
What the registry record for NCT02456389 still lists
NCT02456389 is an interventional study that assigns participants to a tested intervention. Its 1,456 participants enrollment target places it among the larger protocols in the corpus, below the 52,840-participant average among 120 other Surgery trials with a reported enrollment target (97% lower).
The record links to 4 conditions, with Surgery appearing as the primary indexed condition, and to 5 interventions - of which Preoperative risk stratification is the first listed.
NCT02456389 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02456389 about?
NCT02456389 is a clinical study titled "Perioperative Risk Study". The primary objective of this trial is to determine if perioperative risk stratification and risk-based, protocol-driven management leads to a reduction in the rate of death or serious complications compared to standard perioperative management in patients undergoing elective major cancer surgery.
What is the current status of trial NCT02456389?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,456 participants. The study started on 2014-08. Estimated completion is 2025-06.
What conditions does trial NCT02456389 study?
This clinical trial studies the following conditions: Surgery, Tumors, Primary Neoplasm, Secondary Neoplasm.
What interventions are being tested in trial NCT02456389?
The interventions under investigation include: Preoperative risk stratification (OTHER), Postoperative risk stratification (OTHER), Risk-based, escalating levels of care (OTHER), Risk-based, escalating levels of monitoring (OTHER), Risk-based, escalating levels of co-management (OTHER).
Who is sponsoring clinical trial NCT02456389?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02456389 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02456389's enrollment target sits among peer trials
1,456 8th of 120 higher than 113 of 120 other Surgery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of the Use of 3D Technology to Guide Head and Neck Surgery
RECRUITING · NA
-
INCLUDE Program: A Perioperative Wellness Program Tailored for Black Surgical Patients
RECRUITING · NA
-
Ultrasound Evaluation for Improving Patient Selection in vNOTES
RECRUITING · NA
-
Gastric US in ICU Patient
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Physical Therapy After Endometriosis Excision
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03936361 · 1,456 participants · Phase 3
Statins In Intracerbral Hemorrhage
- NCT06782347 · 1,454 participants · NA
Activating SilverSneakers Benefits for Seniors With Osteoarthritis
- NCT04566328 · 1,450 participants · Phase 3
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- NCT05229341 · 1,450 participants · NA
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia